Drug intelligence / Profile preview

SynoviG3

Development stage
Unknown
Lead developer
Elanco
Administration
Oral
01

Overview

SynoviG3 is a veterinary dietary supplement formulated as flavored soft chews or chewable tablets for dogs to support hip and joint health, flexibility, and normal muscle function. The product combines glucosamine hydrochloride to support cartilage matrix and joint lubrication, methylsulfonylmethane (MSM) as a sulfur donor with anti‑inflammatory and connective‑tissue support properties, creatine monohydrate to aid muscle strength, and green‑lipped mussel and omega‑3 fatty acids to provide additional chondroprotective and anti‑inflammatory effects.[1][2][3][5] It is marketed primarily for active dogs or those with stiffness after activity to help maintain healthy joints and cartilage, and is sold through veterinarians and retail channels as an over‑the‑counter companion‑animal joint supplement.[1][2][3][5][6][7]

Brand names
SynoviG3SynoviG-3SynoviG 3
Other names
Synovi G3 Joint Health FormulaSynovi G3 Joint Health Soft ChewsPet Protect Hip & Joint with Synovi G3

Beyond the preview

Go deeper on SynoviG3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SynoviG3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call